Andrew D. Dickinson - 10 Dec 2024 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chief Financial Officer
Signature
/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol
GILD
Transactions as of
10 Dec 2024
Net transactions value
-$155,685
Form type
4
Filing time
11 Dec 2024, 19:05:28 UTC
Previous filing
03 Dec 2024
Next filing
17 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +3,640 +2.6% 142,559 10 Dec 2024 Direct F1
transaction GILD Common Stock Tax liability $155,685 -1,686 -1.2% $92.34 140,873 10 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -3,640 -9.3% 35,487 10 Dec 2024 Common Stock 3,640 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.